Items where Author is "Penichet, Manuel L."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Sun, Tao and Patil, Rameshwar and Galstyan, Anna and Klymyshyn, Dmytro and Ding, Hui and Chesnokova, Alexandra and Cavenee, Webster K. and Furnari, Frank B. and Ljubimov, Vladimir A. and Shatalova, Ekaterina S. and Wagner, Shawn and Li, Debiao and Mamelak, Adam N. and Bannykh, Serguei I. and Patil, Chirag G. and Rudnick, Jeremy D. and Hu, Jethro and Grodzinski, Zachary B. and Rekechenetskiy, Arthur and Falahatian, Vida and Lyubimov, Alexander V. and Chen, Yongmei L. and Leoh, Lai S. and Daniels-Wells, Tracy R. and Penichet, Manuel L. and Holler, Eggehard and Ljubimov, Alexander V. and Black, Keith L. and Ljubimova, Julia Y. (2019) Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk. CANCER RESEARCH, 79 (6). pp. 1239-1251. ISSN 0008-5472, 1538-7445

Galstyan, Anna and Markman, Janet L. and Shatalova, Ekaterina S. and Chiechi, Antonella and Korman, Alan J. and Patil, Rameshwar and Klymyshyn, Dmytro and Tourtellotte, Warren G. and Israel, Liron L. and Braubach, Oliver and Ljubimov, Vladimir A. and Mashouf, Leila A. and Ramesh, Arshia and Grodzinski, Zachary B. and Penichet, Manuel L. and Black, Keith L. and Holler, Eggehard and Sun, Tao and Ding, Hui and Ljubimov, Alexander V. and Ljubimova, Julia Y. (2019) Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. NATURE COMMUNICATIONS, 10: 3850. ISSN 2041-1723

Inoue, Satoshi and Ding, Hui and Portilla-Arias, Jose and Hu, Jinwei and Konda, Bindu and Fujita, Manabu and Espinoza, Andres and Riley, Sonal Suhane Marisa and Gates, Marcus and Patil, Rameshwar and Penichet, Manuel L. and Ljubimov, Alexander V. and Black, Keith L. and Holler, Eggehard and Ljubimova, Julia Y. (2011) Polymalic Acid-Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting both HER2/neu Receptor Synthesis and Activity. CANCER RESEARCH, 71 (4). pp. 1454-1464. ISSN 0008-5472

This list was generated on Fri Jul 17 01:00:43 2026 CEST.